Cargando…

DLC-1:a Rho GTPase-activating protein and tumour suppressor

The deleted in liver cancer 1 (DLC-1) gene encodes a GTPase activating protein that acts as a negative regulator of the Rho family of small GTPases. Rho proteins transduce signals that influence cell morphology and physiology, and their aberrant up-regulation is a key factor in the neoplastic proces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Durkin, Marian E, Yuan, Bao-Zhu, Zhou, Xiaoling, Zimonjic, Drazen B, Lowy, Douglas R, Thorgeirsson, Snorri S, Popescu, Nicholas C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2007
Materias:	Special Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401278/ https://www.ncbi.nlm.nih.gov/pubmed/17979893 http://dx.doi.org/10.1111/j.1582-4934.2007.00098.x

Ejemplares similares

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics
por: ZIMONJIC, DRAZEN B., et al.
Publicado: (2012)

DLC1: a tumor suppressor that regulates Rho signaling
por: Tripathi, Brajendra K., et al.
Publicado: (2017)

DLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctions
por: Tripathi, Veenu, et al.
Publicado: (2014)

DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway
por: Yang, Zheng, et al.
Publicado: (2019)

Acquired genetic and functional alterations associated with transforming growth factor β type I resistance in Hep3B human hepatocellular carcinoma cell line
por: Zimonjic, Drazen B, et al.
Publicado: (2009)

DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
por: Wang, Dunrui, et al.
Publicado: (2016)

SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions
por: Tripathi, Brajendra K., et al.
Publicado: (2019)

Effects of Structure of Rho GTPase-activating Protein DLC-1 on Cell Morphology and Migration
por: Kim, Tai Young, et al.
Publicado: (2008)

CDK5 is a major regulator of the tumor suppressor DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2014)

Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
por: Tripathi, Brajendra K., et al.
Publicado: (2021)

Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2017)

Proteasomal turnover of the RhoGAP tumor suppressor DLC1 is regulated by HECTD1 and USP7
por: Frey, Yannick, et al.
Publicado: (2022)

In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
por: Zimonjic, Drazen B, et al.
Publicado: (2013)

The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1
por: Sanchez-Solana, Beatriz, et al.
Publicado: (2021)

Functional analysis of the Drosophila RhoGAP Cv-c protein and its equivalence to the human DLC3 and DLC1 proteins
por: Sotillos, Sol, et al.
Publicado: (2018)

The tumour suppressor DLC2 ensures mitotic fidelity by coordinating spindle positioning and cell–cell adhesion
por: Vitiello, Elisa, et al.
Publicado: (2014)

Regulation of white and brown adipocyte differentiation by RhoGAP DLC1
por: Sim, Choon Kiat, et al.
Publicado: (2017)

Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
por: Golding, Adriana E, et al.
Publicado: (2019)

Author Correction: Functional analysis of the Drosophila RhoGAP Cv-c protein and its equivalence to the human DLC3 and DLC1 proteins
por: Sotillos, Sol, et al.
Publicado: (2020)

Spatial Rho regulation: Molecular mechanisms controlling the GAP protein DLC3
por: Hendrick, Janina, et al.
Publicado: (2016)

Role of Rho GTPases in inflammatory bowel disease
por: Li, Xiaoling, et al.
Publicado: (2023)

LD Motif Recognition by Talin: Structure of the Talin-DLC1 Complex
por: Zacharchenko, Thomas, et al.
Publicado: (2016)

Deregulation of Rho GTPases in cancer
por: Porter, Andrew P., et al.
Publicado: (2016)

RhoGTPase in Vascular Disease
por: Strassheim, Derek, et al.
Publicado: (2019)

Rho GTPases in ameloblast differentiation
por: Otsu, Keishi, et al.
Publicado: (2016)

Rho Family GTPases in Cancer
por: Dharmawardhane, Suranganie
Publicado: (2021)

Role of Rho-GTPases in megakaryopoiesis
por: Vainchenker, William, et al.
Publicado: (2021)

Rho GTPases in Model Systems
por: Filić, Vedrana, et al.
Publicado: (2023)

Regulation of Rho GTPases by RhoGDIs in Human Cancers
por: Cho, Hee Jun, et al.
Publicado: (2019)

Rho Family GTPases and Rho GEFs in Glucose Homeostasis
por: Machin, Polly A., et al.
Publicado: (2021)

Arf GTPase interplay with Rho GTPases in regulation of the actin cytoskeleton
por: Singh, Vikash, et al.
Publicado: (2017)

Rho GTPases: Anti- or Pro-neoplastic Targets?
por: Zandvakili, Inuk, et al.
Publicado: (2016)

The DLC-1 tumor suppressor is involved in regulating immunomodulation of human mesenchymal stromal /stem cells through interacting with the Notch1 protein
por: Na, Tao, et al.
Publicado: (2020)

SH3 domain regulation of RhoGAP activity: Crosstalk between p120RasGAP and DLC1 RhoGAP
por: Chau, Jocelyn E., et al.
Publicado: (2022)

Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters
por: Fritz, G, et al.
Publicado: (2002)

Rho Gtpases: Integrating Integrin Signaling
por: Ridley, Anne
Publicado: (2000)

Rho GTPases as regulators of morphological neuroplasticity
por: Auer, Maria, et al.
Publicado: (2011)

Regulation of cytokinesis by Rho GTPase flux
por: Miller, Ann L., et al.
Publicado: (2008)

Mechanisms of the proteinuria induced by Rho GTPases
por: Wang, Liming, et al.
Publicado: (2012)

Rho GTPases in endoderm development and differentiation
por: Loebel, David A.F., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ckj0tk7c8ms94uovk009ck6pmh